Results 301 to 310 of about 133,761 (337)

Molecular Signature of Cisplatin Resistance in Ovarian Cancer Identifies Therapeutic Opportunities for Re-sensitization. [PDF]

J Cancer
Mansour M, van Ginkel S, Alata M, Bani I, Elhussin I.   +4 more
europepmc   +1 more source

Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer

Heming Zhou, Huarong Chen, Weixin Liu, Cong Liang, Shiyan Wang, Kai Yuan, Alvin H.K. Cheung, Yuet Wu, Wei Kang, Henley Cheung, Yanqiang Ding, Qinyao Wei, Hao Su, Tianhui Li, Wenxin Luo, Sujun Chen, Chi Chun Wong, Jun Yu   +17 more
openalex   +1 more source

Repurposing Doxycycline to Overcome High-Glucose-Induced Mitochondrial Biogenesis-Mediated Chemoresistance in Colorectal Cancer Cells. [PDF]

J Cell Mol Med
Wu CH, Huang CW, Chen YC, Yip KL, Miao ZF, Su WC, Chang TK, Tsai HL, Yeh YS, Liu HS, Wang JY.   +10 more
europepmc   +1 more source

CRISPR-Cas9 Genome and Double-Knockout Screening to Identify Novel Therapeutic Targets for Chemoresistance in Triple-Negative Breast Cancer. [PDF]

Cancers (Basel)
Shao S, Li S, Huo Y, Tang S, Gökbağ B, Fan K, Huang Y, Wang L, Nagy G, Parvin J, Stover D, Cheng L, Li L.   +12 more
europepmc   +1 more source

Clinical Implications of SRPK1 Expression in Human Tumours: A Comprehensive Pan-Cancer Analysis Based on Multi-Omics Databases

Duzgun D, Oltean S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Extracellular Vesicles in Chemoresistance

2021
Chemotherapy represents the current mainstay therapeutic approach for most types of cancer. Despite the development of targeted chemotherapeutic strategies, the efficacy of anti-cancer drugs is severely limited by the development of drug resistance. Multidrug resistance (MDR) consists of the simultaneous resistance to various unrelated cytotoxic drugs ...
Gabriele, De Rubis, Mary, Bebawy
openaire   +2 more sources